THC BioMed (CSE: THC) Closed Acquistion of U.S. based Clone Shipper LLC

THC Announces Purchase of Clone Shipper LLC

VANCOUVER, May 8, 2017 /CNW/ - THC BioMed Intl Ltd. ("THC" or the "Company") (CSE:THC) announces that it has purchased Clone Shipper LLC for USD $1,000,000. The Issuer will now add the Clone Shipper Business to its existing operations. Clone Shipper is a U.S. based company, specializing in packaging products for the transportation of live plants. [...]

Health Canada Issues THC BioMed amendment to Sell Starting Materials and Grants THC Permission to Conduct In-House Analytical Testing – THC to Expand its Facilities

VANCOUVER, BC–(Marketwired – December 20, 2016) – THC BioMed Intl Ltd. (“THC” or the “Company“) (CSE: THC) (CSE: THC.CN) (CNSX: THC) (OTCQB: THCBF) (FRANKFURT: TFHC) is pleased to announce several new developments relating to its new, amended license from Health Canada, the launch of its revamped website, the expansion of its facilities and changes in [...]

Clone Shippers Scheduled for Delivery to THC BioMed

THC BioMed Ltd.'s Clone Shippers are now scheduled for delivery from the US manufacturer. The Clone Shippers have received subtle design changes specifically to be compliant with Health Canada and the ACMPR, fully approving them for use. THC BioMed Ltd. is looking forward to receiving the first large shipment of Clone Shippers and supplying the [...]

THC BioMed Now Trading on OTCQB Marketplace

THC BioMed Enters Into Exclusive Distribution Agreement With Clone Shipper

For full details read the complete press release here: THC Enters Into Exclusive Distribution Agreement With Clone Shipper

THC BioMed To Acquire Clone Shipper

THC BioMed Releases Packaging Design & Sets Pricing For Its’ 29 Strains At $4.20 / Gram

    THC BioMed Ltd. has completed the design and packaging of the 29 Cannabis strains of dried marijuana that it intends to offer its' patients, registered under the ACMPR, once permission to sell has been granted. All 29 Strains will be priced at $4.20 / gram. THC BioMed has structured pricing to reflect its’ mandate of [...]

THC BioMed Ltd. Demonstrates It’s Readiness To Supply Propagation Material To Patients, As Previewed By Lift Cannabis

Lift Cannabis CEO- Tyler Sookochoff,  Director of Communications - David Brown and contributing author - Natasha Raey paid THC BioMed Ltd. a visit today, to learn more about what the company has been up to, since receiving a Production License from Health Canada, in February. In preparation for receiving the "Sale"provision on the license, THC [...]

THC BioMed’s CEO Comments On Lift Article

Allowing personal production of medical cannabis is a huge step forward, but many questions remain about how feasible to plan will be any time soon. While we still have to wait and see the more minute details of the regulations on August 24th, Health Canada’s announcement last week about the allowance for personal and designated [...]